andy corley yelroc consulting inc
TRANSCRIPT
Andy Corley
Yelroc Consulting Inc.
Co-founded eyeonics, Inc ◦ Developed new category of intraocular lens, the
accommodating IOL, known as Crystalens
◦ Sold to Bausch + Lomb in 2008, served as President of the Surgical Division
Co-founder of Chiron Ophthalmics ◦ General Manager of the Refractive Surgery Division
◦ Played a key role in the introduction of LASIK
2005 Orange County Entrepreneur of the Year
Crystalens 2005 AeA Technology of the Year
Graduate of Georgia Southern University
Owner, Yelroc Consulting Inc.
Senior Consultant to Bausch + Lomb ◦ Was Chairman of the Board of Technolas Perfect Vision,
recently purchased by B+L
Executive Chairman of NeoVista Inc.
Venture Partner at One Focus Ventures
Advisory boards: ◦ UCI School of Biomedical Engineering
◦ Scripps Genomic Institute
[ 4 ] CONFIDENTIAL
The Only Global Company Focused
Solely On Eye Health
[ 5 ]
Rich Heritage
1853
John Jacob
Bausch opens an
optical goods shop
in Rochester, N.Y.
Microscope,
binocular and
telescope
production begins
1893
Ray-Ban
sunglass
line
introduced
Manufactures world’s
first approved
soft contact lens
Acquire Dr. Mann
Pharma and
Pharmafair, Inc. to
form pharma business
segment
Develop
PureVision
SiHy
contact lens
2008
Lotemax
ophthalmic
steroid
launched
1870 –
1900 1910s 1930s 1970s 1980s 1990s
First optical quality
glass produced in
America
ReNu all-in-one
contact lens
cleaning solution
introduced
2000s
Divest
refractive
surgery
business thru
formation of
joint venture
with 2010
Perfect Vision
Besivance
antbacterial
launched
Acquisitions of
Groupe Chauvin,
CT Freda,
eyeonics and
Tubilux expand
pharma and
surgical portfolios
PureVision2HD
contact lenses
launched
Establish
present
business model
via
acquisition of
surgical
product lines
and divestiture
of sunglass and
other non-core
business lines
Crystalens AO
launched for
cataract
patients
BioTrue
multipurpose
solution
launched
[ 6 ]
Global Reach and Perspective
Revenues in
100+ Countries ~11,000 Global
Employees
Manufacturing
in 9 Countries
6 Major Global
D&R Sites
[ 7 ]
Aging
population 65+ age group (~630 MM) expected to double by 2030 (~1.2 Bn)1
Type 2
Diabetes Number of cases doubled over last 30 years2; increasing prevalence
Expanding
Middle Class Increasing demand & willingness to pay for eye health services
Heightened
innovation Comfort, safety and efficacy enhanced through technology
Emerging
markets Contributing up to ~50% of global GDP growth through the decade3
Eye health is resilient to economic and legislative factors
Key Macro Trends Fueling Demand for Eye Health Services
1 Source: United Nations Population Division World Population Prospects, 2010 Revision 2 Source: USA Today, “Diabetes on the Upswing”, 6/25/2011 3 Source: World Market Monitor
[ 8 ]
Solely Focused on Eye Health
Geographic Expansion
Focus on Execution
Internal and External Pipeline Growth
Brand and Scale
PHARMA VISION
CARE
SURGICAL
Customers+ Patients
[ 9 ]
Broad Product Portfolio
Surgical Pharmaceutical Vision Care
Multipurpose Solutions
Contact Lenses
Cosmetic Contact Lenses
Ocular Vitamin
Antibiotic
Dry Eye Antiviral
Anti-inflammatory
Intraocular Lenses (IOLs)
Surgical Equipment
[ 10 ]
Surgical Serving the Needs of Ophthalmic Surgeons Worldwide
Refractive
Retinal
Cataract
[ 11 ]
Cataract Surgery
Most Commonly Performed Surgery in the World
Surgical Equipment Intraocular Lenses (IOLs) Surgical Instruments/Packs
Akreos® IOLs
Viscoelastics
[ 12 ]
Retinal Surgery
Treating eye problems of the
retina, macula, and vitreous fluid
Surgical Equipment Surgical Instruments
[ 13 ]
Refractive Surgery
Performed to decrease or
eliminate dependency on glasses or contact lenses
Surgical Equipment Surgical Instruments
TECHNOLAS® Excimer Workstation
ZYOPTIX® Diagnostic Workstation